CDF CEO, Marilyn Geller, will present the celiac patient voice at the May 11 FDA Patient-Focused Drug Development meeting. Have your voice be heard. Complete the CDF Celiac PFDD Survey now.
Continue ReadingCeliac Disease Foundation Chief Executive Officer, Marilyn Geller, attended The State of Autoimmune Disease: A National Summit at the National Press Club in Washington, D.C. The Summit explored the current trends in diagnosis, treatment, and therapies, presented by experts in research, environment, advocacy, and patient issues.
Continue ReadingOn March 30-31st, 2015, Celiac Disease Foundation Chief Executive Officer, Marilyn G. Geller, attended the FDA Public Workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3) near Washington,…
Continue ReadingCeliac Disease Foundation is pleased to announce our participation in the Autoimmune Research Network, known as ARNet. ARNet is a network of autoimmune disease advocacy organizations that will foster research into celiac…
Continue ReadingOn March 1 and 2, 2015, Talia Hassid, Celiac Disease Foundation’s Community Coordinator, attended the Digestive Disease National Coalition Public Policy Forum held in Washington DC. The forum gathers representatives from digestive disease organizations across the U.S. together to arrive at a common agenda to influence health care policy in the United States.
Continue ReadingOn March 23rd, join CDF at The State of Autoimmune Disease: A National Summit at the National Press Club in Washington, DC. The summit will bring together leading experts in research, environment, advocacy and patient issues to explore the most current trends in autoimmune disease diagnosis, treatments and therapies.
Continue ReadingLearn from experts from the Celiac Program at Harvard Medical School at the inaugural CEU-based medical and nutrition conference titled “Gluten Free for Life: A Comprehensive Toolkit for Diagnosing and Treating Celiac Disease and Other Gluten-Related Disorders” with separate healthcare professionals and patient tracks.
Continue ReadingLOS ANGELES, Calif., Feb. 6, 2015 –Celiac Disease Foundation today sent a letter to California Attorney General Kamala Harris, asking that she issue notifications to GNC Holdings, Inc., Target Corporation, Walgreens and Wal-Mart Stores,…
Continue ReadingThe Celiac Disease Foundation Medical Advisory Board, together with the National Board of Directors submitted a letter to the U.S. Preventive Services Task Force supporting the North American Society for the Study of Celiac Disease (NASSCD) comments on the Task Force's draft research plan for screening for celiac disease. Among other comments, the NASSCD encouraged the USPSTF to focus on high risk individuals (those who are symptomatic, have associated diseases or a family history) in their research.
Continue ReadingAffecting 1% of the population, celiac disease is one of the world’s most prevalent genetic autoimmune conditions. In the United States, celiac disease is also one of the least diagnosed,…
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...